array(3) { ["company_details"]=> array(13) { ["name"]=> string(24) "Idexx Laboratories, Inc." ["slug"]=> string(31) "52dfe-us-idexx-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62" ["description"]=> string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities." ["address_street"]=> string(10) "1 Idexx Dr" ["address_place"]=> string(9) "Westbrook" ["address_region"]=> string(5) "Maine" ["founding_date"]=> string(10) "1983-02-28" ["website_domain"]=> string(9) "idexx.com" ["website_url"]=> string(21) "https://www.idexx.com" ["industry_codes"]=> array(4) { [0]=> string(43) "General Livestock, Except Dairy and Poultry" [1]=> string(33) "Veterinary Services for Livestock" [2]=> string(27) "Pharmaceutical Preparations" [3]=> string(42) "In Vitro and In Vivo Diagnostic Substances" } ["employee_count"]=> int(710) ["article_count"]=> int(643) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(84) "Will Avid Bioservices (USA Stocks:CDMO) investors shift to IDEXX (USA Stocks:IDXX)?" ["snippet_en"]=> string(295) "Despite Avid Bioservices' (USA Stocks: CDMO) current market capitalization of $400.9M and Wall Street's target price of $12.25, the company's financial health raises concerns due to its EBITDA showing a loss of $501K and a negative operating margin of -0.44. Given these factors, investors might" ["url"]=> string(131) "https://www.macroaxis.com/invest/story/CDMO/31258361/Will-Avid-Bioservices-USA-Stocks-CDMO-investors-shift-to-IDEXX-USA-Stocks-IDXX" ["image_url"]=> string(78) "https://images.businessradar.com/articles/72c924fb-8278-46f6-8a41-59e4046dc4fa" ["source"]=> string(13) "macroaxis.com" ["publication_date"]=> string(10) "2024-04-07" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(9) "Investors" [2]=> string(15) "Market Movement" } } [1]=> array(7) { ["title_en"]=> string(107) "Investors are avoiding the IDEXX Laboratories share today: the price is falling significantly (€491.1639)" ["snippet_en"]=> string(120) "One of the big losers on the stock market today is IDEXX Laboratories shares. The security loses significantly in value." ["url"]=> string(92) "https://www.ariva.de/news/investoren-meiden-heute-die-idexx-laboratories-aktie-kurs-11111817" ["image_url"]=> string(78) "https://images.businessradar.com/articles/383ee36d-3455-4346-97ab-7ac95c8253ef" ["source"]=> string(8) "ariva.de" ["publication_date"]=> string(10) "2024-01-12" ["categories"]=> array(7) { [0]=> string(21) "Shareholders Feedback" [1]=> string(24) "Stock Research & Ratings" [2]=> string(9) "Investors" [3]=> string(15) "Market Movement" [4]=> string(18) "General Investment" [5]=> string(21) "Competitive Behaviour" [6]=> string(12) "Stock Market" } } [2]=> array(7) { ["title_en"]=> string(28) "10 High-Risk Stocks to Avoid" ["snippet_en"]=> string(304) "Investors face many different types of financial risk. There’s the most basic risk—the risk of losing money. And then there’s the risk of missing your goals or, for retirees, the risk of outliving your assets. Investors who invest conservatively run the risk of not keeping up with inflation, while" ["url"]=> string(75) "https://www.morningstar.ca/ca/news/232638/10-high-risk-stocks-to-avoid.aspx" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2ba170f6-fbfd-4370-8c6e-a014ad54b17a" ["source"]=> string(14) "morningstar.ca" ["publication_date"]=> string(10) "2023-12-11" ["categories"]=> array(5) { [0]=> string(24) "Systemic Risk Management" [1]=> string(9) "Investors" [2]=> string(18) "General Investment" [3]=> string(18) "Financial Distress" [4]=> string(12) "Stock Market" } } [3]=> array(7) { ["title_en"]=> string(55) "ALC or IDXX: Which Is the Better Value Stock Right Now?" ["snippet_en"]=> string(230) "Investors with an interest in Medical - Instruments stocks have likely encountered both Alcon (ALC) and Idexx Laboratories (IDXX). But which of these two stocks presents investors with the better value opportunity right now? Let's" ["url"]=> string(86) "https://www.nasdaq.com/articles/alc-or-idxx:-which-is-the-better-value-stock-right-now" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-11-16" ["categories"]=> array(5) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(9) "Investors" [2]=> string(15) "Market Movement" [3]=> string(18) "General Investment" [4]=> string(12) "Stock Market" } } [4]=> array(7) { ["title_en"]=> string(55) "IDEXX Laboratories (IDXX) Fell on Investors’ Concerns" ["snippet_en"]=> string(255) "Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The market rally that was driven by technology this year came to a halt in the third quarter." ["url"]=> string(87) "https://hk.finance.yahoo.com/news/idexx-laboratories-idxx-fell-investors-170025554.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a3643510-4bce-4d86-9855-511dd1522e43" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-11-11" ["categories"]=> array(6) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(9) "Investors" [2]=> string(15) "Market Movement" [3]=> string(31) "Financial Update/Profit Warning" [4]=> string(18) "General Investment" [5]=> string(12) "Stock Market" } } [5]=> array(7) { ["title_en"]=> string(55) "IDEXX Laboratories (IDXX) Fell on Investors’ Concerns" ["snippet_en"]=> string(255) "Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The market rally that was driven by technology this year came to a halt in the third quarter." ["url"]=> string(84) "https://finance.yahoo.com/news/idexx-laboratories-idxx-fell-investors-170025554.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/0cb4817a-d90d-4134-9e8e-4cbc7b5de8f3" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-11-11" ["categories"]=> array(6) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(9) "Investors" [2]=> string(15) "Market Movement" [3]=> string(31) "Financial Update/Profit Warning" [4]=> string(18) "General Investment" [5]=> string(12) "Stock Market" } } [6]=> array(7) { ["title_en"]=> string(77) "IDEXX Laboratories shares hold up well today: share value rises (€398.7669)" ["snippet_en"]=> string(190) "The shares of IDEXX Laboratories are currently trading somewhat more firmly on the US stock exchange. Most recently, investors paid $426.86 for the paper. Shareholders can currently be happy" ["url"]=> string(146) "https://www.finanznachrichten.de/nachrichten-2023-11/60605515-idexx-laboratories-aktie-heute-gut-behauptet-aktienwert-steigt-398-7669-euro-013.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7595e4d2-08b6-45b3-ad5e-99f39afa1c34" ["source"]=> string(20) "finanznachrichten.de" ["publication_date"]=> string(10) "2023-11-08" ["categories"]=> array(9) { [0]=> string(21) "Shareholders Feedback" [1]=> string(24) "Stock Research & Ratings" [2]=> string(9) "Investors" [3]=> string(15) "Market Movement" [4]=> string(14) "Issuing Shares" [5]=> string(18) "General Investment" [6]=> string(12) "Stock Market" [7]=> string(12) "Going Public" [8]=> string(16) "Share Repurchase" } } [7]=> array(7) { ["title_en"]=> string(25) "5 Marvelous Mid-Cap Funds" ["snippet_en"]=> string(72) "In theory, midsize-company stocks operate in a sweet spot for investors." ["url"]=> string(90) "https://www.kiplinger.com/slideshow/investing/t041-s002-marvelous-mid-cap-funds/index.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/80ec25af-7a22-4089-be01-930f87d57d7b" ["source"]=> string(13) "kiplinger.com" ["publication_date"]=> string(10) "2019-12-27" ["categories"]=> array(3) { [0]=> string(18) "General Investment" [1]=> string(12) "Stock Market" [2]=> string(9) "Investors" } } [8]=> array(7) { ["title_en"]=> string(55) "Idexx Laboratories shares: A surprise for investors! ()" ["snippet_en"]=> string(72) "Idexx Laboratories shares: A surprise for investors! () | aktiencheck.de" ["url"]=> string(109) "https://www.aktiencheck.de/analysen/Artikel-Idexx_Laboratories_Aktie_Eine_Ueberraschung_fuer_Anleger-16724654" ["image_url"]=> NULL ["source"]=> string(14) "aktiencheck.de" ["publication_date"]=> NULL ["categories"]=> array(5) { [0]=> string(9) "Investors" [1]=> string(14) "Issuing Shares" [2]=> string(18) "General Investment" [3]=> string(12) "Stock Market" [4]=> string(16) "Share Repurchase" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(117) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(67) } [2]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(44) } [3]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(43) } [4]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(40) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(22) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(22) } [8]=> array(2) { ["name"]=> string(12) "Restatements" ["count"]=> int(21) } [9]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(18) } [11]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [12]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(12) } [14]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(9) } [16]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(31) "Water and Wastewater Management" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(5) } } } 52dfe-us-idexx-laboratories-inc